1.Pathogeny and treatment of 50 nasopharyngeal tuberculosis cases.
Yiluan JIAN ; Baoying LIU ; Lixia GUO ; Shaoyan KONG ; Xiaomin SU ; Chunli LU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2012;26(24):1138-1140
OBJECTIVE:
To analyze the clinical characters and treatment of nasopharyngeal tuberculosis, and to provide a scientific basis for improving clinical diagnosis of nasopharyngeal tuberculosis.
METHOD:
The clinical materials of 50 patients diagnosed as nasopharyngeal tuberculosis in Guangzhou Chest Hospital were reviewed and analyzed. All the 50 patients were given regular antituberculosis treatment with 3HRZS(E)/9HR(E) for one year, and were treated through nasal spray with combination medication of isoniazid, rifampicin and streptomycin injection solution for 3 months.
RESULT:
All patients were cured through regular antituberculosis treatment for one year, and no recrudescence cases were found in 2 years of follow-up.
CONCLUSION
Nasopharyngeal tuberculosis is rare and the clinical manifestation is atypical. It is extremely easy to cause clinical misdiagnosis. A full understanding of the pathogenesis, timely clinical characters under nasopharyngoscope and histopathological examination results are the keys to diagnosis, and to giving regular antituberculosis treatment to obtain satisfactory curative effect.
Adolescent
;
Adult
;
Aged
;
Antitubercular Agents
;
therapeutic use
;
Female
;
Humans
;
Male
;
Middle Aged
;
Nasopharyngeal Diseases
;
diagnosis
;
drug therapy
;
microbiology
;
Tuberculosis
;
diagnosis
;
drug therapy
;
Young Adult
2.Plasma levels of interferon-inducible protein 10 in patients with active pulmonary tuberculosis with different affected areas.
Haiping DONG ; Zhihui LIU ; Xiaocheng LIANG ; Yiluan JIAN ; Dexian LI ; Suihua LAO ; Feng LIANG ; Yanshan PAN ; Xiaojia KUANG
Journal of Southern Medical University 2019;39(5):609-613
OBJECTIVE:
To explore the value of interferon-inducible protein 10 (IP-10) in the auxiliary diagnosis of tuberculosis and the judgment of the severity of disease.
METHODS:
From February, 2013 to February, 2017, a total of 193 patients with TB admitted in our hospital and 84 healthy control subjects were recruited consecutively. The peripheral blood plasma levels of interferon-γ (IFN-γ) and IP-10 were detected using liquid phase chip (Luminex) technique. According to the number of lung fields affected by TB, the patients were divided into group A (with lesions in 1-2 lung fields), group B (3-4 lung fields) and group C (5-6 lung fields), The expressions of IFN-γ and IP-10 in 3 groups were compared.
RESULTS:
The plasma levels of IP-10 were significantly higher in TB patients than in the control subjects ( < 0.05), but IFN-γ levels were comparable between the two groups ( > 0.05). Among the TB patients, plasma IP-10 levels was the highest in group C ( < 0.05), and IFN-γ levels did not differ significantly among the 3 groups ( > 0.05).
CONCLUSIONS
Plasma IP-10 has a certain reference value in the auxiliary diagnosis of active tuberculosis and the judgment of the severity of the disease.
Antigens, Bacterial
;
Biomarkers
;
blood
;
Chemokine CXCL10
;
blood
;
Humans
;
Tuberculosis, Pulmonary
;
blood
;
diagnosis